Goldman Sachs Group Inc Oncolytics Biotech Inc Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 84,998 shares of ONCY stock, worth $77,348. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,998
Previous 83,598
1.67%
Holding current value
$77,348
Previous $82,000
10.98%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ONCY
# of Institutions
44Shares Held
1.18MCall Options Held
0Put Options Held
0-
Seeds Investor LLC New York, NY190KShares$172,8460.06% of portfolio
-
International Assets Investment Management, LLC Orlando, FL174KShares$158,6410.55% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il79.2KShares$72,1160.0% of portfolio
-
Royal Bank Of Canada Toronto, A674.5KShares$67,8360.0% of portfolio
-
Commonwealth Equity Services, LLC61.1KShares$55,6130.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $52.7M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...